Batimastat sodium salt (BB-94) is a broad-spectrum matrix metalloproteinase (MMP) inhibitor with potent anti-neoplastic and anti-angiogenic activities; it effectively inhibits MMP-1, -2, -3, -7, and -9 (IC50 = 3, 4, 20, 6, and 4 nM, respectively); blocks CD30 shedding from Karpas 299 cells (IC50 = 230 nM); suppresses human ovarian carcinoma xenograft growth and murine melanoma metastasis; delays primary tumor growth in an orthotopic human breast cancer model; and, when combined with cisplatin, completely prevents tumor growth and spread in xenograft models, significantly improving survival rates.